Hospira Recalls Lidocaine Hydrochloride Injection Due to Particulate Matter
Hospira is recalling specific vials of 1% Lidocaine Hydrochloride Injection because a returned sample contained human hair attached to the stopper.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The agency classification is FDA Class I, which mandates a minimum severity score of 4 per the rubric, as it represents a reasonable probability of serious adverse health consequences or death.
Plain-English summary
Hospira Inc. is recalling 100,100 units of 1% Lidocaine Hydrochloride Injection, USP, 10 mg/mL, 30 mL Single-dose, Preservative-Free glass vials. The recall is limited to Lot# 40-316-DK with an expiration date of 01APR2016. The product is identified by NDC 0409-4279-02.
The recall was initiated after a returned customer sample was evaluated and found to have human hair attached to a pinched area of the stopper. This constitutes the presence of particulate matter in the product.
The affected product was distributed nationwide. Consumers and healthcare providers should check their inventory for the specific lot number and expiration date listed above. If the product is found, it should be removed from use and returned to the distributor or manufacturer according to standard recall procedures.
The recalled product
- Product
- LIDOCAINE HYDROCHLORIDE (LIDOCAINE HYDROCHLORIDE)
- Brand
- LIDOCAINE HYDROCHLORIDE
- Manufacturer
- Hospira Inc.
- Category
- Drug — Injection
- Affected units
- 100,100
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot# 40-316-DK
- Exp 01APR2016
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · LIDOCAINE HYDROCHLORIDE
- SevereLidocaine Hydrochloride Injection Recalled for Sterility Assurance
FDA (Drugs) · 2026-07-08
- HighSpectra lidocaine ampules recalled over lack of sterility assurance
FDA (Drugs) · 2026-06-10
- HighHuons lidocaine 2% injection recalled over lack of sterility assurance
FDA (Drugs) · 2026-04-22
- HighHuons lidocaine injection recalled nationwide over lack of sterility assurance
FDA (Drugs) · 2026-04-22
- SevereLidocaine injection recalled due to glass particulate matter
FDA (Drugs) · 2023-11-15
Same manufacturer · Hospira Inc.
See all →- CriticalHospira Recalls Dextrose Injection Syringes Due to Human Hair Particulate
FDA (Drugs) · 2017-05-31
- ModerateHospira Recalls Minibore Extension Sets Due to Solvent Occlusion
FDA (Devices) · 2017-01-18
- LowHospira Recalls Lidocaine and Dextrose Injection for Stability Failures
FDA (Drugs) · 2016-12-14
- SevereHospira Recalls Fentanyl Citrate Injection Ampules Due to Broken Tips
FDA (Drugs) · 2016-11-30
- HighHospira Symbiq Infusion Pump Recall for White Screen Safety Shutdown
FDA (Devices) · 2016-11-16
Same hazard · particulate matter
See all →- SevereACTHAR Gel Recalled for Presence of Glass and Stopper Particulate Matter
FDA (Drugs) · 2026-09-02
- SevereB. Braun Recalls Lactated Ringer's Injection Due to Particulate Matter
FDA (Drugs) · 2026-09-02
- CriticalAmerican Regent Recalls Papaverine Hydrochloride Injection Due to Particulate Matter
FDA (Drugs) · 2026-08-26
- SevereAmerican Regent Recalls Nitroglycerin Injection Due to Particulate Matter
FDA (Drugs) · 2026-08-26
- SevereAmerican Regent Recalls Cyanocobalamin Injections Due to Particulate Matter
FDA (Drugs) · 2026-08-26